Prospective Electronic Polygenic Risk Study - Second Phase
Prospective Electronic Polygenic Risk Study - Second Phase
Not yet recruiting · NCT05175651 · Registry updated 2022-11-07Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Prospective Electronic Polygenic Risk Study - Second Phase | Arterial Occlusive Diseases, arteriosclerosis disorder, cardiovascular disorder, coronary artery disorder, eye disorder, glaucoma, heart disorder, myocardial ischemia, ocular hypertension, vascular disorder | Not yet recruiting | Not applicable | 2022-11-07 | NCT05175651 |
4 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Illumina, Inc. | 7 |
| Optum, Inc. | 4 |
| Quest Diagnostics-Nichols Insitute | 5 |
| Scripps Translational Science Institute | 19 |
0 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| No products are listed yet. | |||